News & Events

ObsEva in the News
View All News

ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

31 Jul 2018

Press Release in Pdf

Geneva, Switzerland and Boston, MA – July 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that it will release its second quarter 2018 financial results on Wednesday, August 8, 2018. ObsEva management will host an investment community conference call at 8 a.m. Eastern Daylight Time, 2 p.m. Central European Summer Time, on August 8, 2018 to discuss these financial results and provide a corporate update.

Investors may participate by dialing (844) 419-1772 for U.S. callers and +1 (213) 660-0921 for international callers, and referring to conference ID 6749875. A webcast of the conference call can be accessed under the “Investors” section of ObsEva’s website www.obseva.com.

 

About ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol "OBSV", as well as on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”.

For more information, please visit www.ObsEva.com.

###

For more information, please contact:

 

Media Contact Switzerland and Europe:

Christophe Lamps

Dynamics Group

cla@dynamicsgroup.ch

+41 22 308 6220 Office

+41 79 476 26 87 Mobile

 

Media Contact U.S.:

Jeanene Timberlake

RooneyPartners LLC

jtimberlake@rooneyco.com

+1 646 770 8858

 

CEO Office Contact:

Shauna Dillon

Shauna.dillon@obseva.ch

+41 22 552 1550

 

Investor Contact:

Mario Corso

Senior Director, Investor Relations

mario.corso@obseva.com

+1 857 972 9347 Office +1 781 366 5726 Mobile

Media Contact

Switzerland & Europe:

Christophe Lamps
Dynamics Group 
+41 79 476 26 87
cla@dynamicsgroup.ch

U.S.:

Marion Janic
RooneyPartners LLC
+1 212-223-4017
mjanic@rooneyco.com